About this trial
The goal of this clinical trial is to compare the efficacy of two surgical techniques-anterior and posterior white line advancement-for the correction of primary aponeurotic ptosis in adult patients. The main questions it aims to answer are:
Does the anterior approach lead to a greater improvement in Marginal Reflex Distance 1 (MRD1) at 6 months compared to the posterior approach?
Are there differences in eyelid symmetry, contour, visual function, and patient satisfaction between the two techniques?
Researchers will compare the anterior approach group to the posterior approach group to see if one offers better functional and aesthetic outcomes, fewer complications, or higher patient satisfaction.
Participants will:
Be randomly assigned to receive either anterior or posterior white line advancement surgery.
Undergo preoperative and postoperative evaluations at 7 days, 2 months, and 6 months, including:
Measurements of eyelid position (MRD1), contour, and symmetry
Vision and tear film tests (e.g., refraction, TBUT, Schirmer's test)
Surveys on dry eye symptoms (OSDI), scar quality (POSAS 2.0), satisfaction, and psychosocial function
Monitoring of surgical time and complications
Eligibility criteria
Qualifiers
Age over 18 years.
Diagnosis of primary aponeurotic upper eyelid ptosis.
Levator muscle function of 12 mm or greater.
Provision of written informed consent after receiving adequate information about the study.
Disqualifiers
Diagnosis of non-aponeurotic eyelid ptosis.
Poor levator muscle function.
History of recurrent eyelid ptosis or previous eyelid ptosis surgery.
Medical or surgical history that, in the investigator's judgment, may interfere with participation.
Trial design
Treatments tested in this trial
- Anterior White Line Advancement Surgery
- Posterior White Line Advancement Surgery